slides · global inventory
Source Note
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 110,355
Current window 56,911-56,940
Pages 3,679
Rows per page 30
Component
56,911-56,940 of 110,355
36
The slide uses a comparative bar chart structure to highlight Athene's superior performance across three key financial dimensions.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof1 hit
37
The slide uses a mix of pie charts for business mix and bar charts for scale and growth metrics to highlight Athene's relative size and performance.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof1 hit
40
The slide uses a numbered list format to structure the valuation arguments.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank Beat · Evidence & Proof1 hit
42
The slide uses a table structure to show how adding capital-intensive assets (Retirement Services) increases total economics compared to a standard asset management model.Apollo Global Management | Mergers and Acquisitions Presentation Deck | 48 slides · Apollo Global Management
Conference presentation Investment bank 1 hit
04
Uses a biological process diagram to explain mechanism of action.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Before After1 hit
06
The slide uses a series of four big-number metrics to communicate clinical efficacy.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising Success1 hit
10
The slide uses a process flow diagram to illustrate the clinical trial protocol.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations Beat · Rising SuccessLoop · Quick Win Big Bet1 hit
13
The slide compares CR and CRc rates for ITT and patients with >= 2 cycles, while noting 30-day mortality and adverse risk classification.argenx SE | Results Presentation Deck | 20 slides · argenx
Conference presentation Investor relations 1 hit
04
The slide uses a high-contrast table to contrast prevalence vs mortality across different disease states.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
05
The slide uses a three-column structure: current portfolio, historical performance chart, and future pipeline.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
07
The slide uses color-coded regions on a world map with callout circles to summarize regional metrics.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
09
The slide uses a three-column layout to frame the problem, the current solution/progress, and the strategic approach.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
10
The slide uses a three-column layout to present market data and strategic initiatives.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
13
The slide lists 6 points (5R + digital), though the title refers to the 5R framework.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
14
The slide uses a stacked bar chart to compare AstraZeneca (first bar) against five competitors (R, P, N, J, M).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
16
The slide outlines a multi-stage R&D process involving data integration, AI analysis, and biological validation.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
17
The slide uses a grid-based categorization of drug modalities.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
18
The slide uses a three-column layout to present project metrics, chemical safety improvements, and biological efficacy results.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
19
The slide uses a combination of process flow, microscopy imagery, and a bar chart to demonstrate the therapeutic potential of HVP cells.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
20
The central cycle diagram illustrates the efficiency gains (1 vs 3 years, 1000 vs 2500 compounds).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
21
The slide uses a four-column layout to present distinct technological approaches to clinical trial optimization.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
22
The slide uses a process flow at the top and a four-pillar framework at the bottom to explain the trial's methodology.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Loop · Hypothesis Test1 hit
26
The slide uses a Gantt-style chart to visualize the compression of development phases.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
27
The slide uses a comparison structure between clinical trial data and real-world evidence.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
29
The slide uses a three-column layout to present product features, scientific data, and clinical trial status.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations 1 hit
36
The slide uses a four-column layout to map disease areas to specific patient outcomes, prevalence data, and therapeutic candidates.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
37
Phase I SAD data presented with dose-response curves for 20mg, 30mg, 60mg, 90mg, and 120mg cohorts.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
39
The slide uses a three-panel structure to compare preclinical rodent models (left/center) with clinical trial data (right).AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
40
The slide combines a biological mechanism diagram with two bar charts showing clinical efficacy data.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit
41
The slide uses color coding to distinguish between highlighted medicines and others in the pipeline.AstraZeneca | Investor Day Presentation Deck | 86 slides · AstraZeneca
Conference presentation Investor relations Beat · Market Size1 hit